Both in Pharmaceuticals
NanoViricides vs SCYNEXIS
Over the past year NNVC returned −5.2% and SCYX returned −30.9%; their daily moves had a correlation of 0.04.
NNVC −5.2% SCYX −30.9%Growth of $1, one year, split-adjusted
| Metric | NNVC | SCYX |
|---|---|---|
| Price | $1.45 | $3.95 |
| Market cap | $37.0M | $39.3M |
| Today | −0.68% | +3.95% |
| 1 month | +11.5% | −15.2% |
| 6 months | +18.9% | −47.2% |
| Year to date | +28.3% | −21.9% |
| 1 year | −9.9% | −34.4% |
| Revenue growth (YoY) | — | −82.8% |
| Gross margin | — | 100.0% |
| Net margin | — | 3147.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.0× |
| Net cash | $2.8M | $54.1M |
| Dividend yield | — | — |
| Volatility (60d) | 89.0% | 64.5% |
| Short % of float | 4.6% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).